Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.46 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.45 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.42 |
| ▸ | GLO1 | Q04760 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16819856 | 1.00 | SLC15A2 (0.49) | SLC15A2PTGS1GSTK1SLC6A5CPB2 | |
| SCHEMBL16819865 | 0.96 | SLC15A2 (0.48) | SLC15A2PTGS1GSTK1SLC6A5CPB2 | |
| SCHEMBL16819863 | 0.96 | SLC15A2 (0.48) | SLC15A2PTGS1GSTK1SLC6A5CPB2 | |
| SCHEMBL15413175 | 0.93 | SLC15A2 (0.47) | SLC15A2PTGS1GSTK1SLC6A5CPB2 | |
| SCHEMBL16819851 | 0.90 | SLC15A2 (0.55) | SLC15A2SLC6A5CPB2CYP3A4SLC7A5 | |
| SCHEMBL15426898 | 0.90 | SLC15A2 (0.55) | SLC15A2SLC6A5CPB2CYP3A4SLC7A5 | |
| SCHEMBL15413155 | 0.90 | PTGS1 (0.44) | SLC15A2PTGS1GSTK1SLC6A5GLO1 | |
| SCHEMBL16819853 | 0.86 | SLC15A2 (0.53) | SLC15A2SLC6A5CPB2CYP3A4SLC7A5 | |
| SCHEMBL16819855 | 0.86 | SLC15A2 (0.53) | SLC15A2SLC6A5CPB2CYP3A4SLC7A5 | |
| SCHEMBL16819888 | 0.86 | SLC15A2 (0.54) | SLC15A2SLC6A5CPB2CYP3A4SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10028935-B2 | Stabilized multi-functional antioxidant compounds and methods of use | XPD HOLDINGS, LLC (US) | 2018-07-24 | — | — | US | claimed |
| US-20170135986-A1 | STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE | XPD HOLDINGS, LLC | 2017-05-18 | — | — | US | claimed |
| US-9382211-B2 | Stabilized multi-functional antioxidant compounds and methods of use | XPD HOLDINGS, LLC (US) | 2016-07-05 | — | — | US | claimed |
| US-20150175552-A1 | STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE | XPD HOLDINGS, LLC | 2015-06-25 | — | — | US | claimed |
| US-10028935-B2 | Stabilized multi-functional antioxidant compounds and methods of use | XPD HOLDINGS, LLC (US) | 2018-07-24 | — | — | US | disclosed |
| US-10028935-B2 | Stabilized multi-functional antioxidant compounds and methods of use | XPD HOLDINGS, LLC (US) | 2018-07-24 | — | — | US | disclosed |
| US-20170135986-A1 | STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE | XPD HOLDINGS, LLC | 2017-05-18 | — | — | US | disclosed |
| US-20170135986-A1 | STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE | XPD HOLDINGS, LLC | 2017-05-18 | — | — | US | disclosed |
| US-9593079-B2 | Stabilized multi-functional antioxidant compounds and methods of use | XPD HOLDINGS, LLC (US) | 2017-03-14 | — | — | US | disclosed |
| US-9382211-B2 | Stabilized multi-functional antioxidant compounds and methods of use | XPD HOLDINGS, LLC (US) | 2016-07-05 | — | — | US | disclosed |
| US-9382211-B2 | Stabilized multi-functional antioxidant compounds and methods of use | XPD HOLDINGS, LLC (US) | 2016-07-05 | — | — | US | disclosed |
| US-20160185718-A1 | Stabilized Multi-Functional Antioxidant Compounds and Methods of Use | XPD HOLDINGS, LLC | 2016-06-30 | — | — | US | disclosed |
| US-20150175552-A1 | STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE | XPD HOLDINGS, LLC | 2015-06-25 | — | — | US | disclosed |
| US-20150175552-A1 | STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE | XPD HOLDINGS, LLC | 2015-06-25 | — | — | US | disclosed |
| WO-2014011624-A2 | STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE | XPD HOLDINGS LLC (US) | 2014-01-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10028935-B2 | Stabilized multi-functional antioxidant compounds and methods of use | SOD1, GPX4, SOD3 | SLC15A2 2163/4885PTGS1 965/4885GSTK1 26/4885 |
| US-20150175552-A1 | STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE | SOD1, GPX4, SOD3 | SLC15A2 2163/4885PTGS1 965/4885GSTK1 26/4885 |
| US-20170135986-A1 | STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE | SOD1, GPX4, SOD3 | SLC15A2 2163/4885PTGS1 965/4885GSTK1 26/4885 |
| US-20160185718-A1 | Stabilized Multi-Functional Antioxidant Compounds and Methods of Use | SOD1, GPX4, SOD3 | SLC15A2 2163/4885PTGS1 965/4885GSTK1 26/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.